These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1576039)

  • 1. Thrombolytics.
    Ostrow CL
    AACN Clin Issues Crit Care Nurs; 1992 May; 3(2):423-36. PubMed ID: 1576039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolytic therapy in acute myocardial infarction.
    Paspa PA; Movahed A
    Am Fam Physician; 1992 Feb; 45(2):640-8. PubMed ID: 1739049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tissue-type plasminogen activator and anisoylated plasminogen streptokinase activator complex on mortality in acute myocardial infarction.
    Held PH; Teo KK; Yusuf S
    Circulation; 1990 Nov; 82(5):1668-74. PubMed ID: 2146038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous thrombolytic therapy in myocardial infarction: an analytical review.
    Shammas NW; Zeitler R; Fitzpatrick P
    Clin Cardiol; 1993 Apr; 16(4):283-92. PubMed ID: 8458108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy in Europe: current status.
    Vahanian A
    Eur Heart J; 1996 Sep; 17 Suppl E():21-7. PubMed ID: 11824000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current issues concerning thrombolytic therapy for acute myocardial infarction.
    Hennekens CH; O'Donnell CJ; Ridker PM; Marder VJ
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):18S-22S. PubMed ID: 7775709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis in acute myocardial infarction.
    Holmberg SR
    Br J Hosp Med; 1992 Apr 15-May 5; 47(8):572-6, 578-80. PubMed ID: 1591557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylated plasminogen-streptokinase activator complex: a new approach to thrombolytic therapy.
    Crabbe SJ; Grimm AM; Hopkins LE
    Pharmacotherapy; 1990; 10(2):115-26. PubMed ID: 2140889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic, antiplatelet, and antithrombotic agents.
    Grines CL
    Am J Cardiol; 1992 Dec; 70(21):18I-26I. PubMed ID: 1471601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?
    Handlin LR; Vacek JL
    Postgrad Med; 1994 Mar; 95(4):77-82. PubMed ID: 8121861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytic drugs in acute myocardial infarct].
    Ambrosioni E; Degli Esposti D
    Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic therapy: then and now.
    Cole PL
    Heart Lung; 1991 Sep; 20(5 Pt 2):542-51. PubMed ID: 1910023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What you should know about thrombolytic therapy for acute MI.
    Aragon D; Martin M
    Am J Nurs; 1993 Sep; 93(9):24-31; quiz 33. PubMed ID: 8213959
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombolytic therapy in acute myocardial infarction.
    Rutherford JD; Braunwald E
    Chest; 1990 Apr; 97(4 Suppl):136S-145S. PubMed ID: 2108851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL; Rothbard RL; Hackworthy RA; Sorensen SG; Fitzpatrick PG; Dahl CF; Hagan AD; Browne KF; Symkoviak GP; Menlove RL
    J Am Coll Cardiol; 1988 Jun; 11(6):1153-63. PubMed ID: 3284943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the various thrombolytic agents equally effective in the treatment of acute transmural myocardial infarction?
    Claessens J; Haseldonckx C
    Jpn Heart J; 1992 Jul; 33(4):413-21. PubMed ID: 1453546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of time to treatment on early infarct-related artery patency after different thrombolytic regimens. ALKK-Study Group.
    Zeymer U; Tebbe U; Essen Rv; Haarmann W; Neuhaus KL
    Am Heart J; 1999 Jan; 137(1):34-8. PubMed ID: 9878934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic aspects of treatment of acute myocardial infarction with thrombolytic agents.
    Woo KS; White HD
    Pharmacoeconomics; 1993 Mar; 3(3):192-204. PubMed ID: 10172049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial.
    Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD
    J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.